RAEB
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (NCT02562443) | Traws Pharma, Inc. | 2015-12-02 |
| Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts (NCT01241500) | Traws Pharma, Inc. | 2010-11-01 |
Track RAEB automatically
Every clearance here is in the API, with alerts when new ones post.